Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

CohBar, Inc. CWBR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

CohBar, Inc. (CWBR) is a Biotechnology company in the Healthcare sector, currently trading at $0.41. It has a SharesGrow Score of 45/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Net income is $12M (loss), growing at +3.3%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $15M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 15.69 (strong liquidity). Debt-to-assets is 0%. Total assets: $16M.

Analyst outlook: 5 / 5 analysts rate CWBR as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 45/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 28/100 (Fail), Future 100/100 (Pass), Income ?/100 (Fail).

CWBR SharesGrow Score Overview

60/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 45/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 100/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CWBR

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
45/100
CWBR: +0%/yr revenue is, +3.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet CWBR: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 15.69 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
CWBR: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
100/100
Analyst outlook: 5 / 5 analysts rate CWBR as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0011-1.01
Volume172
Avg Volume (30D)3.04K
Market Cap$1.19M
Beta (1Y)1.38
Share Statistics
EPS (TTM)-4.13
Shares Outstanding$2.9M
IPO Date2017-12-15
Employees9
CEOPinchas Cohen Dean,
Financial Highlights & Ratios
EBITDA$-12.29M
Net Income$-11.96M
Operating Income$-12.39M
Total Cash$15.74M
Net Debt$-5.93M
Total Assets$16.37M
Price / Earnings (P/E)-0.1
Analyst Forecast
Rating ConsensusBuy
Analysts Covering5
Buy 100% Hold 0% Sell 0%
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS19249J3077

Price Chart

Track all markets on TradingView
CWBR
CohBar, Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Biotechnology
0.00 52WK RANGE 1.01

People Also View

ZURA
ZURA
Zura Bio Limited
$5.72
+0.70%
 ELEV
ELEV
Elevation Oncology, Inc.
$0.37
-2.12%
 AVRO
AVRO
AVROBIO, Inc.
$1.40
-1.41%
 ENVB
ENVB
Enveric Biosciences, Inc.
$1.95
-1.02%
 HEPA
HEPA
Hepion Pharmaceuticals, Inc.
$0.05
+18.52%
 OCEA
OCEA
Ocean Biomedical, Inc.
$0.00
+0.00%
 EFTR
EFTR
eFFECTOR Therapeutics, Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message